APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis

Area of Science:

• Nephrology
• Mitochondrial Biology
• Metabolomics

Background:

• Kidney risk variants (KRVs) in the APOL1 gene are linked to mitochondrial dysfunction.
• The specific metabolites and mitochondrial pathways affected by APOL1 G1 and G2 KRVs are not well understood.

Purpose of the Study:

• To investigate the molecular and metabolic consequences of APOL1 G1 and G2 KRVs.
• To identify affected metabolites and downstream mitochondrial pathways relevant to nephropathy.

Main Methods:

• Metabolomics analysis was conducted on HEK293 cells expressing APOL1 G0, G1, and G2 KRVs.
• Statistical analyses included Welch's t-test, paired t-test, and ANOVA to identify differential metabolites.
• Random forest classification was employed to prioritize key metabolites.

Main Results:

• APOL1 KRVs significantly altered the tricarboxylic acid cycle.
• Increased fatty acid oxidation and compromised redox homeostasis were observed.
• Differential metabolite patterns were identified and prioritized.

Conclusions:

• Impairment of mitochondrial respiratory chain complex I is a critical metabolic consequence of APOL1 KRVs.
• These findings support the role of APOL1 variants in mitochondrial membrane potential depletion.
• The study elucidates metabolic pathways affected by APOL1-associated nephropathy.